NEW YORK (GenomeWeb News) – Genentech has licensed Genizon Biosciences’ GeneMap of Crohn’s disease to support drug and diagnostics development, Genizon said today.
 
Under the agreement, Genizon will receive an undisclosed upfront payment, research funding, and milestone payments for each therapeutic developed through the collaboration.
 
GeneMap’s disease-associated genes were generated from a whole genome association study of 500 families from the Quebec Founder Population.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.

Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.

Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.